Medical Device | April 28, 2026
Concept Medical unveils promising 3-year data for sirolimus balloon therapy
The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease
The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease
The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
Relmada expects to initiate its Phase 3 program in the first half of 2026
Long-term OGSIVEO treatment for up to four years associated with further tumor reductions, increased objective response rate, sustained symptom improvement, and consistent safety profile
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Launch of Indian public health standards for Ayush healthcare facilities
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
Subscribe To Our Newsletter & Stay Updated
